Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases

E-ISSN： 1873-4286|10|2|203-211

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.2, 2004-01, pp. : 203-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory and Accessory HIV-1 Proteins: Potential Targets for HIV-1 Vaccines?

Current Medicinal Chemistry, Vol. 12, Iss. 6, 2005-01 ,pp. : 741-747

Bentham Science Publishers

Access to resources Recommend Favorite

The Future Use of Complement Inhibitors for the Treatment of Neurological Diseases

By McGeer E.G. McGeer P.L.

Drugs, Vol. 55, Iss. 6, 1998-06 ,pp. : 739-746

Adis International

Access to resources Recommend Favorite

The Possibilities and Pitfalls for Anti-Complement Therapies in Inflammatory Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 1, 2004-03 ,pp. : 87-96

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of complement inhibitors in myocardial ischaemia

By Tanhehco E.J. Lucchesi B.R.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 975-991

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targets of Diabetic Vascular Complications and Potential New Drugs

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 503-509

Bentham Science Publishers

Access to resources Recommend Favorite